Business
Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China, Hong Kong and Macau
Hi, what are you looking for?
Jewish Business News
Business
Teva to Receive Worldwide Development and Commercial Rights to Novel CGRP Antagonists; Heptares to Receive $10 Million Upfront with up to $400 Million in...
Life science
Pfizer will hold a 10% stake in the Israeli company, as part of its acquisition of Allergan.
Business
Impax, Stada, Taro may be takeover targets for Mylan, Perrigo; Mylan may also look for assets shed in Teva-Allergan deal
Business
Perrigo is acquiring gastroenterology drug Entocort from AstraZeneca.
Business
Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.
Business
Hospital officials from Tomsk visited Israel to scout out biomed and telemed companies for the Siberian region’s new Medicine of the Future project.
Business
Mylan's Executive Chairman Robert Coury: we are well-positioned to quickly execute on the next strategic, value-enhancing opportunities for our business, some of which we...
Mergers & Acquisitions
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Business
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...